Evidence map›Paper›PMID 12905030›Full record

ArticlePflugers Archiv : European journal of physiology2003

A radiolabeled peptide ligand of the hERG channel, [125I]-BeKm-1.

Kamilla Angelo, Yuliya V Korolkova, Morten Grunnet, Eugene V Grishin, Kirill A Pluzhnikov, Dan A Klaerke, Hans-Günther Knaus, Morten Møller, Søren-Peter Olesen

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Pflugers Archiv : European journal of physiology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Cardiac hERG KHandbook of experimental pharmacology · 2021
    Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Kamilla AngeloThe Wolfson Institute for Biomedical Research, Cruciform Building, University College London, Gower Street, London, WC1E 6BT, UK. k.angelo@ucl.ac.uk
Yuliya V Korolkova
Morten Grunnet
Eugene V Grishin
Kirill A Pluzhnikov
Dan A Klaerke
Hans-Günther Knaus
Morten Møller
Søren-Peter Olesen
University of Copenhagen · DKRussian Academy of Sciences · RUInstitute of Bioorganic Chemistry · RUUniversität Innsbruck · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The wild-type scorpion toxin BeKm-1, which selectively blocks human ether-a-go-go related (hERG) channels, was radiolabeled with iodine at tyrosine 11. Both the mono- and di-iodinated derivatives were found to be biologically active. In electrophysiological patch-clamp recordings mono-[127I]-BeKm-1 had a concentration of half-maximal inhibition (IC50 value) of 27 nM, while wild-type BeKm-1 inhibited hERG channels with an IC50 value of 7 nM. Mono-[125I]-BeKm-1 was found to bind in a concentration-dependent manner and with picomolar affinity to hERG channel protein in purified membrane vesicles from transfected human embryonic kidney cells (HEK-293). Under optimized conditions the equilibrium dissociation constant ( Kd) values from saturation and kinetic binding analysis were 13 and 14 pM, respectively. Both the association and dissociation of [(125)I]-BeKm-1 were fast (association rate constant, k(on)=3.6 x 10(7) M(-1)s(-1); dissociation rate constant, k(off)=0.005 s(-1)). Wild-type BeKm-1 displaced binding of [125I]-BeKm-1 with half-maximal inhibitory concentrations of 44 pM. In contrast, competition experiments with a BeKm-1 mutant BeKm-1-K18A, in which the toxin interaction site is disrupted, resulted in a drop in affinity by more than 300-fold as compared to the wild-type toxin. Iberiotoxin and apamin, peptide inhibitors of Ca2+-activated K+-channels, had no effect on [125I]-BeKm-1 binding. Adding the classical rapid delayed rectifier current (IKr) blocker E-4031 reduced binding of [125I]-BeKm-1 to the hERG channel to an IC50 of 7 nM. In autoradiographic studies on rat hearts, binding of [125I]-BeKm-1 was dose-dependent and could partially be displaced by the addition of excess amounts of non-radioactive BeKm-1. The density of the radioactive signal was equally distributed in the myocardium of both the ventricle and atria indicating a homogenous expression of hERG channels throughout the heart.

Indexed as

Potassium Channels, Voltage-GatedAnimalsCell LineDose-Response Relationship, DrugERG1 Potassium ChannelEther-A-Go-Go Potassium ChannelsHumansIodine RadioisotopesLigandsMalePeptidesPotassium Channel BlockersPotassium ChannelsProtein BindingRatsScorpion VenomsBeKm-1 toxinERG1 Potassium ChannelEther-A-Go-Go Potassium ChannelsIodine RadioisotopesKCNH2 protein, humanLigandsPeptidesPotassium Channel BlockersPotassium ChannelsPotassium Channels, Voltage-GatedScorpion Venoms

Identifiers

PMID12905030
OpenAlexW2061587885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.